Long-Term Efficacy and Safety of the Microsomal Triglyceride Transfer Protein Inhibitor Lomitapide in Patients With Homozygous Familial Hypercholesterolemia

被引:104
|
作者
Blom, Dirk J. [1 ]
Averna, Maurizio R. [2 ]
Meagher, Emma A. [3 ]
Theron, Hendrik du Toit [4 ]
Sirtori, Cesare R.
Hegele, Robert A. [5 ,6 ]
Shah, Prediman K. [7 ]
Gaudet, Daniel [8 ]
Stefanutti, Claudia [9 ]
Vigna, Giovanni B. [10 ]
Larrey, Dominique [11 ]
Bloedon, LeAnne T. [12 ]
Foulds, Pamela [12 ]
Rader, Daniel J. [3 ]
Cuchel, Marina [3 ]
机构
[1] Univ Cape Town, Cape Town, South Africa
[2] Univ Palermo, Palermo, Italy
[3] Univ Penn, Philadelphia, PA 19104 USA
[4] Netcare Private Hosp, Bloemfontein, South Africa
[5] Osped Niguarda Ca Granda, Milan, Italy
[6] Univ Western Ontario, London, ON, Canada
[7] Cedars Sinai Heart Inst, Los Angeles, CA USA
[8] Univ Montreal, Chicoutimi, PQ, Canada
[9] Univ Roma Sapienza, Rome, Italy
[10] Univ Ferrara, Ferrara, Italy
[11] CHRU Montpellier, Montpellier, France
[12] Aeger Pharmaceut, Cambridge, MA USA
关键词
lomitapide;
D O I
10.1161/CIRCULATIONAHA.117.028208
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:332 / 335
页数:4
相关论文
共 50 条
  • [1] Lomitapide–a Microsomal Triglyceride Transfer Protein Inhibitor for Homozygous Familial Hypercholesterolemia
    Claudia Stefanutti
    Current Atherosclerosis Reports, 2020, 22
  • [2] Microsomal triglyceride transfer protein inhibitor (lomitapide) efficacy in the treatment of patients with homozygous familial hypercholesterolemia phenotype
    Fountas, E.
    Diakoumakou, O.
    Kolovou, V.
    Stratakis, S.
    Zacharis, E.
    Liberopoulos, E.
    Matsouka, F.
    Tsoutsinos, A.
    Mastorakou, I.
    Katsikas, T.
    Mavrogeni, S.
    Hatzigeorgiou, G.
    Kolovou, G.
    EUROPEAN HEART JOURNAL, 2019, 40 : 3258 - 3258
  • [3] Lomitapide-a Microsomal Triglyceride Transfer Protein Inhibitor for Homozygous Familial Hypercholesterolemia
    Stefanutti, Claudia
    CURRENT ATHEROSCLEROSIS REPORTS, 2020, 22 (08)
  • [4] Review of the long-term safety of lomitapide: a microsomal triglycerides transfer protein inhibitor for treating homozygous familial hypercholesterolemia
    Khoury, Etienne
    Brisson, Diane
    Roy, Nathalie
    Tremblay, Gerald
    Gaudet, Daniel
    EXPERT OPINION ON DRUG SAFETY, 2019, 18 (05) : 403 - 414
  • [5] Microsomal triglyceride transfer protein inhibitor (lomitapide) efficacy in the treatment of patients with homozygous familial hypercholesterolaemia
    Kolovou, Genovefa
    Diakoumakou, Olga
    Kolovou, Vana
    Fountas, Epameinondas
    Stratakis, Stavros
    Zacharis, Evangelos
    Liberopoulos, Evangelos N.
    Matsouka, Fedra
    Tsoutsinos, Alexandros
    Mastorakou, Irene
    Katsikas, Theodoros
    Mavrogeni, Sophie
    Hatzigeorgiou, Georgios
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2020, 27 (02) : 157 - 165
  • [6] A phase 3 study of the microsomal triglyceride transfer protein (MTP) inhibitor lomitapide in patients with homozygous familial hypercholesterolemia
    Cuchel, M.
    EUROPEAN HEART JOURNAL, 2012, 33 : 951 - 951
  • [7] Long-term clinical results of microsomal triglyceride transfer protein inhibitor use in a patient with homozygous familial hypercholesterolemia
    Raper, Anna
    Kolansky, Daniel M.
    Sachais, Bruce S.
    Meagher, Emma A.
    Baer, Amanda L.
    Cuchel, Marina
    JOURNAL OF CLINICAL LIPIDOLOGY, 2015, 9 (01) : 107 - 112
  • [8] Apheresis Treatment does not Affect the Lipid-Lowering Efficacy of Lomitapide, a Microsomal Triglyceride Transfer Protein Inhibitor, in Patients with Homozygous Familial Hypercholesterolemia
    Cuchel, Marina
    Meagher, Emma A.
    Theron, H. du Toit
    Blom, Dirk
    Marais, A. D.
    Hegele, Robert A.
    Averna, Maurizio
    Sirtori, Cesare
    Shah, Prediman K.
    Gaudet, Daniel
    Stefanutti, Claudia
    Vigna, Giovanni B.
    du Plessis, A. M. E.
    Bloedon, LeAnne T.
    Rader, Daniel J.
    CIRCULATION, 2012, 126 (21)
  • [10] Efficacy and Safety of Lomitapide in Japanese Patients with Homozygous Familial Hypercholesterolemia
    Harada-Shiba, Mariko
    Ikewaki, Katsunori
    Nohara, Atsushi
    Otsubo, Yoshihiko
    Yanagi, Koji
    Yoshida, Masayuki
    Chang, Qing
    Foulds, Pamela
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2017, 24 (04) : 402 - 411